Project Grant K08DE034837
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$170K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This $229,440 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports research to investigate the mechanistic basis for differential responses to radio-immunotherapy in head and neck squamous cell carcinoma (HNSCC) and pancreatic ductal adenocarcinoma (PDAC). The research aims to elucidate how the tumor microenvironment, particularly the role of regulatory T cells (Tregs), impacts...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), will provide $701,699 to The General Hospital Corporation (Massachusetts General Hospital) to conduct research on the spatial regulators of the hybrid epithelial/mesenchymal state and its impact on immune infiltration in head and neck squamous cell carcinoma. The research will: 1) further define the effect of this...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $109,548 Project Grant under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121) to the Regents of the University of Michigan. The grant supports a research project focused on investigating the role of myeloid cells in the evolution of precancerous oral lesions to head and neck squamous cell carcinoma (HNSCC). The project aims to develop a preclinical mouse model to study the transition from...
The Project Grant award R01DE033695, in the amount of $353,763, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121). The grant supports research to investigate the mechanisms by which increased interleukin-1 (IL-1) signaling may lead to sustained interleukin-8 (IL-8) signaling and NADPH oxidase 2 (NOX2)-derived superoxide production, which are associated with pro-survival signaling...
This $517,993 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to investigate the role of FOSL1 super-enhancers in determining the functional properties of cisplatin-enriched cancer stem cells (CSCs) in head and neck squamous cell carcinoma (HNSCC). The award recipient, Virginia Commonwealth University (VCU), will utilize novel proteolysis targeting chimera (PROTAC)...
This Project Grant award, valued at $1,915,027.00, was issued on June 6, 2024 by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121). The grant supports research by Trustees of Boston University to define the role of age-associated mechanical signals in head and neck cancer (HNSCC) progression and immune evasion. The research aims to examine the relationship between aging, extracellular matrix...
This $390,000 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under its Oral Diseases and Disorders Research program (CFDA 93.121), supports research to leverage single-cell co-culture and gene expression profiling to identify tumor antigen-specific T cells in oral squamous cell carcinoma (OSCC). The key products and services to be delivered include: Optimizing a high-throughput, single-cell co-culture system to isolate individual tumor-killing T...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $204,688 to The Johns Hopkins University to develop novel immunotherapies for HPV-associated head and neck cancers. The research focuses on three key products: 1) Salmonella-derived nanoparticles (SOMV-9RE7) to effectively stimulate the immune system, 2) Albumin-fused cytokines (ALB-FLT3L and ALB-IFNB) to expand...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $1,676,355 project grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the University of Pittsburgh. The grant, awarded on July 1, 2024, will support a 5-year research project to investigate how opioid usage suppresses anti-tumor immunity and limits the effectiveness of immune checkpoint inhibitor (ICI) therapy in head and neck squamous cell carcinoma (HNSCC). The research will use...
This $434,170 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports the development and evaluation of a novel engineered bacterial in situ vaccination platform for oral cancer immunotherapy. The key products and services to be delivered under this award include: Development of potent and programmable non-pathogenic E. coli bacteria that can be biomaterial-encapsulated to...